Global Health Limited · ASX:GLH
Global Health — Proactive Lifesciences Webinar (August 2021)
11 slides from Global Health's conference presentation, Aug 10, 2021
Slide 1: Proactive Lifesciences Webinar Presentation
For personal use only Proactive Lifesciences Webinar Presentation 10 August 2021
Slide 2: Disclaimer
Disclaimer This Presentation contains summary information about Global Health Limited ACN 091 377 892 (Global Health or the Company) and its activities as at [insert]. The information in this Presentation is of a general nature and does not purport to be complete or comprise all information which a
Slide 3: Six Reasons to Invest in Global Health
Six Reasons to Invest in Global Health Key Investment Drivers For personal use only Uniquely positioned in the Healthcare sector with digitisation a big focus in a COVID-19 environment Strong Board, Leadership and Management Team with newly appointed CEO, Michael Davies highly focused to drive s
Slide 4: Your Health System
Your Health System Australia’s annual expenditure on healthcare was $185B in 2017-18. Healthcare expenditure has grown at a rate For personal use only of 4.3% p.a. since 2001 (Source: AIHW). With over 70% already being spent on chronic disease management each year, without innovation and disruption,
Slide 5: What we do at Global Health
For personal use only What we do at Global Heath: Specialists In Supporting The Delivery Of Community Chronic Disease Management Services SaaS Subscription Model to Connect Healthcare Providers and Consumers Global Health develops, owns and markets a suite of software and SaaS platforms that connect
Slide 6: Our Strength - Community Health Market
Our Strength - Community Health Market For personal use only Community Health Organisations deliver primary health, human services and support to local communities. They sit alongside general practice and privately funded services to make up the primary healthcare sector Our Market Leading Software
Slide 7: FY21(f) Revenue of A$6.9m
FY21(f) Revenue of A$6.9m Approximate EBIT breakeven position for FY21, achieved with only 1 sales person. Significant For personal use only investment in sales from cap raise expected to drive 25%+ p.a recurring revenue growth going forward Half-Year (6mth) Revenue Trend FY(12mth) Revenue Trend $4,
Slide 8: Our new CEO - Michael Davies
Our new CEO - Michael Davies (from 1st July) For personal use only • New CEO at Global Health • 20 Years of sales experience across leading groups including Telstra, Optus and most recently as Head of Revenue for Macquarie Telecom • Big focus in career on sales generation, strong leadership with dem
Slide 9: To Recap: Drivers for Revenue Growth in FY21/22
To Recap: Drivers for Revenue Growth in FY21/22 For personal use only Increase M&A MasterCare into Targeting community hospitals from Victoria to accelerated 25%+ p.a Size of Prize Nation-wide Upsell recurring Lifecard and revenue growth HotHealth products with an Upgrade expanded and MasterCare’s l
Slide 10: Board of Directors
Board of Directors For personal use only ROBERT KNOWLES AO GRANT SMITH MATHEW CHERIAN STEVEN PYNT Non-Executive Director Non-Executive Director Executive Director Chairman of Global Health Robert is a former Victorian Minister of Health, Grant has had great involvement in the private Mathew has had
Slide 11: For Further Information
For personal use only For Further Information Mathew Cherian Rod North – Investor Relations, Media & PR Executive Director, Global Health Limited Managing Director, Bourse Communications T: (03) 9675 0600, M: 0409 099 788 T: (03) 9510 8309, M: 0408 670 706 E: Mathew.Cherian@global-health.com E: rod@
Global Health — Proactive Lifesciences Webinar (August 2021) on 6ix